Vespa velutina chromosome 5, iVesVel2.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespa.
REFSEQ INFORMATION: The reference sequence is identical to\nOU525127.1.\nAssembly name: iVesVel2.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2021/08/14. The original whole-genome shotgun project has the\naccession CAJVVP000000000.1.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespa velutina Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
beta-1,4-glucuronyltransferase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
beta-1,4-glucuronyltransferase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
beta-1,4-glucuronyltransferase 1-like isoform X2
beta-1,4-glucuronyltransferase 1-like isoform X1
potassium channel subfamily K member 10-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
potassium channel subfamily K member 10-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
potassium channel subfamily K member 10-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC124949493 isoform X1
uncharacterized protein LOC124949493 isoform X2
potassium channel subfamily K member 10-like isoform X3
protein tumorous imaginal discs, mitochondrial, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
protein tumorous imaginal discs, mitochondrial isoform X1
protein tumorous imaginal discs, mitochondrial, transcript variant X2
protein tumorous imaginal discs, mitochondrial, transcript variant X3
protein tumorous imaginal discs, mitochondrial isoform X2
ceramide phosphoethanolamine synthase-like, transcript variant X1
ceramide phosphoethanolamine synthase-like, transcript variant X2
ceramide phosphoethanolamine synthase-like isoform X1
ceramide phosphoethanolamine synthase-like, transcript variant X3
ceramide phosphoethanolamine synthase-like isoform X2
uncharacterized LOC124949491, transcript variant X5
uncharacterized LOC124949491, transcript variant X6
uncharacterized LOC124949491, transcript variant X2
uncharacterized LOC124949491, transcript variant X1
uncharacterized LOC124949491, transcript variant X4
uncharacterized LOC124949491, transcript variant X3
SET domain-containing protein SmydA-8-like
programmed cell death protein 6, transcript variant X2
programmed cell death protein 6, transcript variant X1
programmed cell death protein 6 isoform X2
programmed cell death protein 6 isoform X1
dolichyl-phosphate beta-glucosyltransferase, transcript variant X1
dolichyl-phosphate beta-glucosyltransferase, transcript variant X2
dolichyl-phosphate beta-glucosyltransferase isoform X1
dolichyl-phosphate beta-glucosyltransferase isoform X2
integrin-linked protein kinase homolog pat-4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
BICD family-like cargo adapter 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
BICD family-like cargo adapter 1, transcript variant X5
BICD family-like cargo adapter 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
BICD family-like cargo adapter 1, transcript variant X1
uncharacterized LOC124949329, transcript variant X15
uncharacterized LOC124949329, transcript variant X8
uncharacterized LOC124949329, transcript variant X5
uncharacterized LOC124949329, transcript variant X3
uncharacterized LOC124949329, transcript variant X2
uncharacterized LOC124949329, transcript variant X1
uncharacterized LOC124949329, transcript variant X7
uncharacterized LOC124949329, transcript variant X11
uncharacterized LOC124949329, transcript variant X12
uncharacterized LOC124949329, transcript variant X9
uncharacterized LOC124949329, transcript variant X6
uncharacterized LOC124949329, transcript variant X10
uncharacterized LOC124949329, transcript variant X4
uncharacterized LOC124949329, transcript variant X13
uncharacterized LOC124949329, transcript variant X14
uncharacterized protein LOC124949329 isoform X8
uncharacterized protein LOC124949329 isoform X5
uncharacterized protein LOC124949329 isoform X4
uncharacterized protein LOC124949329 isoform X2
uncharacterized protein LOC124949329 isoform X1
uncharacterized protein LOC124949329 isoform X6
uncharacterized protein LOC124949329 isoform X3
uncharacterized protein LOC124949329 isoform X7
BICD family-like cargo adapter 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
BICD family-like cargo adapter 1 isoform X1
BICD family-like cargo adapter 1 isoform X2
lethal(3)malignant brain tumor-like protein 4, transcript variant X1
lethal(3)malignant brain tumor-like protein 4, transcript variant X3
lethal(3)malignant brain tumor-like protein 4, transcript variant X2
lethal(3)malignant brain tumor-like protein 4, transcript variant X5
lethal(3)malignant brain tumor-like protein 4, transcript variant X4
lethal(3)malignant brain tumor-like protein 4, transcript variant X7
lethal(3)malignant brain tumor-like protein 4, transcript variant X6
lethal(3)malignant brain tumor-like protein 3 isoform X1
lethal(3)malignant brain tumor-like protein 3 isoform X2
lethal(3)malignant brain tumor-like protein 3 isoform X3
lethal(3)malignant brain tumor-like protein 4 isoform X4
protein-L-isoaspartate O-methyltransferase domain-containing protein 1-like, transcript variant X3
protein-L-isoaspartate O-methyltransferase domain-containing protein 1-like, transcript variant X2
protein-L-isoaspartate O-methyltransferase domain-containing protein 1-like, transcript variant X1
protein-L-isoaspartate O-methyltransferase domain-containing protein 1-like
electron transfer flavoprotein beta subunit lysine methyltransferase-like, transcript variant X2
uncharacterized protein LOC124949342 isoform X2
uncharacterized LOC124949325, transcript variant X1
uncharacterized LOC124949325, transcript variant X2
uncharacterized protein LOC124949325 isoform X1
uncharacterized protein LOC124949325 isoform X2
electron transfer flavoprotein beta subunit lysine methyltransferase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
electron transfer flavoprotein beta subunit lysine methyltransferase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC124949325, transcript variant X3
uncharacterized LOC124949325, transcript variant X4
uncharacterized protein LOC124949325 isoform X3
electron transfer flavoprotein beta subunit lysine methyltransferase-like isoform X3
electron transfer flavoprotein beta subunit lysine methyltransferase-like isoform X1
electron transfer flavoprotein beta subunit lysine methyltransferase-like, transcript variant X5
electron transfer flavoprotein beta subunit lysine methyltransferase-like, transcript variant X4
uncharacterized protein LOC124949342 isoform X4
uncharacterized LOC124949325, transcript variant X5
uncharacterized protein LOC124949325 isoform X4
nuclear receptor-binding protein homolog, transcript variant X1
nuclear receptor-binding protein homolog, transcript variant X2
nuclear receptor-binding protein homolog isoform X1
nuclear receptor-binding protein homolog isoform X2
TBC1 domain family member 20, transcript variant X1
TBC1 domain family member 20, transcript variant X3
TBC1 domain family member 20, transcript variant X2
phospholipase A2 group XV-like, transcript variant X1
phospholipase A2 group XV-like, transcript variant X3
phospholipase A2 group XV-like isoform X3
phospholipase A2 group XV-like isoform X1
phospholipase A2 group XV-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
phospholipase A2 group XV-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
CBY1-interacting BAR domain-containing protein 1-A-like isoform X4
CBY1-interacting BAR domain-containing protein 1-B-like isoform X2
secretion-regulating guanine nucleotide exchange factor, transcript variant X4
secretion-regulating guanine nucleotide exchange factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
secretion-regulating guanine nucleotide exchange factor, transcript variant X2
secretion-regulating guanine nucleotide exchange factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
secretion-regulating guanine nucleotide exchange factor isoform X4
secretion-regulating guanine nucleotide exchange factor isoform X3
secretion-regulating guanine nucleotide exchange factor isoform X1
secretion-regulating guanine nucleotide exchange factor isoform X2
ubiquitin-fold modifier 1, transcript variant X2
ubiquitin-fold modifier 1, transcript variant X3
ubiquitin-fold modifier 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC124949346 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
elongation factor Ts, mitochondrial, transcript variant X1
elongation factor Ts, mitochondrial, transcript variant X3
elongation factor Ts, mitochondrial, transcript variant X2
elongation factor Ts, mitochondrial isoform X1
elongation factor Ts, mitochondrial isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 33% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: dynein axonemal heavy chain 7-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
class E basic helix-loop-helix protein 23, transcript variant X1
class E basic helix-loop-helix protein 23, transcript variant X2
class E basic helix-loop-helix protein 23
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X1
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X2
insulin-like growth factor-binding protein complex acid labile subunit isoform X1
insulin-like growth factor-binding protein complex acid labile subunit isoform X2
probable hydroxyacid-oxoacid transhydrogenase, mitochondrial, transcript variant X4
probable hydroxyacid-oxoacid transhydrogenase, mitochondrial, transcript variant X1
probable hydroxyacid-oxoacid transhydrogenase, mitochondrial isoform X1
hydroxyacid-oxoacid transhydrogenase, mitochondrial isoform X3
probable hydroxyacid-oxoacid transhydrogenase, mitochondrial, transcript variant X2
probable hydroxyacid-oxoacid transhydrogenase, mitochondrial, transcript variant X3
probable hydroxyacid-oxoacid transhydrogenase, mitochondrial isoform X2
glyceraldehyde-3-phosphate dehydrogenase 1-like
glyceraldehyde-3-phosphate dehydrogenase 2-like
ralBP1-associated Eps domain-containing protein 1
protein lethal(2)essential for life-like
putative inhibitor of apoptosis, transcript variant X1
putative inhibitor of apoptosis, transcript variant X2
cell division cycle protein 23 homolog, transcript variant X14
cell division cycle protein 23 homolog, transcript variant X10
cell division cycle protein 23 homolog, transcript variant X11
cell division cycle protein 23 homolog, transcript variant X1
cell division cycle protein 23 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cell division cycle protein 23 homolog, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cell division cycle protein 23 homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cell division cycle protein 23 homolog, transcript variant X8
cell division cycle protein 23 homolog, transcript variant X9
cell division cycle protein 23 homolog, transcript variant X6
cell division cycle protein 23 homolog, transcript variant X4
cell division cycle protein 23 homolog, transcript variant X2
cell division cycle protein 23 homolog isoform X2
cell division cycle protein 23 homolog isoform X1
cell division cycle protein 23 homolog isoform X4
cell division cycle protein 23 homolog, transcript variant X12
cell division cycle protein 23 homolog, transcript variant X13
neither inactivation nor afterpotential protein C, transcript variant X4
neither inactivation nor afterpotential protein C, transcript variant X3
neither inactivation nor afterpotential protein C, transcript variant X1
neither inactivation nor afterpotential protein C, transcript variant X2
neither inactivation nor afterpotential protein C, transcript variant X9
neither inactivation nor afterpotential protein C isoform X3
neither inactivation nor afterpotential protein C isoform X2
neither inactivation nor afterpotential protein C isoform X1
neither inactivation nor afterpotential protein C isoform X5
neither inactivation nor afterpotential protein C, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
neither inactivation nor afterpotential protein C, transcript variant X5
neither inactivation nor afterpotential protein C, transcript variant X6
neither inactivation nor afterpotential protein C, transcript variant X11
neither inactivation nor afterpotential protein C, transcript variant X10
neither inactivation nor afterpotential protein C, transcript variant X12
neither inactivation nor afterpotential protein C, transcript variant X8
neither inactivation nor afterpotential protein C isoform X4
neither inactivation nor afterpotential protein C isoform X6
neither inactivation nor afterpotential protein C, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
neither inactivation nor afterpotential protein C, transcript variant X13
neither inactivation nor afterpotential protein C isoform X8
neither inactivation nor afterpotential protein C isoform X7
neither inactivation nor afterpotential protein C, transcript variant X15
neither inactivation nor afterpotential protein C isoform X9
sodium-driven chloride bicarbonate exchanger, transcript variant X4
sodium-driven chloride bicarbonate exchanger, transcript variant X8
sodium-driven chloride bicarbonate exchanger, transcript variant X30
sodium-driven chloride bicarbonate exchanger, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sodium-driven chloride bicarbonate exchanger, transcript variant X9
sodium-driven chloride bicarbonate exchanger, transcript variant X19
sodium-driven chloride bicarbonate exchanger, transcript variant X16
sodium-driven chloride bicarbonate exchanger, transcript variant X12
sodium-driven chloride bicarbonate exchanger, transcript variant X7
sodium-driven chloride bicarbonate exchanger, transcript variant X18
sodium-driven chloride bicarbonate exchanger, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sodium-driven chloride bicarbonate exchanger, transcript variant X14
sodium-driven chloride bicarbonate exchanger, transcript variant X20
sodium-driven chloride bicarbonate exchanger, transcript variant X17
sodium-driven chloride bicarbonate exchanger, transcript variant X10
sodium-driven chloride bicarbonate exchanger, transcript variant X13
sodium-driven chloride bicarbonate exchanger, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sodium-driven chloride bicarbonate exchanger, transcript variant X22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sodium-driven chloride bicarbonate exchanger, transcript variant X26
sodium-driven chloride bicarbonate exchanger, transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sodium-driven chloride bicarbonate exchanger, transcript variant X11
sodium-driven chloride bicarbonate exchanger, transcript variant X28
sodium-driven chloride bicarbonate exchanger, transcript variant X27
electroneutral sodium bicarbonate exchanger 1 isoform X15
sodium-driven chloride bicarbonate exchanger, transcript variant X2
sodium-driven chloride bicarbonate exchanger, transcript variant X1
sodium-driven chloride bicarbonate exchanger, transcript variant X3
sodium-driven chloride bicarbonate exchanger, transcript variant X23
sodium-driven chloride bicarbonate exchanger, transcript variant X24
sodium-driven chloride bicarbonate exchanger, transcript variant X25
electroneutral sodium bicarbonate exchanger 1 isoform X17
electroneutral sodium bicarbonate exchanger 1 isoform X1
electroneutral sodium bicarbonate exchanger 1 isoform X6
sodium-driven chloride bicarbonate exchanger isoform X21
electroneutral sodium bicarbonate exchanger 1 isoform X2
electroneutral sodium bicarbonate exchanger 1 isoform X7
electroneutral sodium bicarbonate exchanger 1 isoform X5
sodium bicarbonate cotransporter 3 isoform X3
sodium bicarbonate cotransporter 3 isoform X8
sodium bicarbonate cotransporter 3 isoform X13
sodium bicarbonate cotransporter 3 isoform X10
electroneutral sodium bicarbonate exchanger 1 isoform X14
electroneutral sodium bicarbonate exchanger 1 isoform X9
electroneutral sodium bicarbonate exchanger 1 isoform X11
electroneutral sodium bicarbonate exchanger 1 isoform X4
electroneutral sodium bicarbonate exchanger 1 isoform X12
sodium bicarbonate cotransporter 3 isoform X19
electroneutral sodium bicarbonate exchanger 1 isoform X16
electroneutral sodium bicarbonate exchanger 1 isoform X18
sodium-driven chloride bicarbonate exchanger, transcript variant X29
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
electrogenic sodium bicarbonate cotransporter 1 isoform X20
bone morphogenetic protein receptor type-2, transcript variant X3
bone morphogenetic protein receptor type-2, transcript variant X4
bone morphogenetic protein receptor type-2, transcript variant X1
bone morphogenetic protein receptor type-2, transcript variant X2
bone morphogenetic protein receptor type-2 isoform X2
bone morphogenetic protein receptor type-2 isoform X1
bone morphogenetic protein receptor type-2 isoform X3
43 kDa receptor-associated protein of the synapse homolog, transcript variant X3
43 kDa receptor-associated protein of the synapse homolog, transcript variant X1
43 kDa receptor-associated protein of the synapse homolog, transcript variant X4
43 kDa receptor-associated protein of the synapse homolog, transcript variant X2
43 kDa receptor-associated protein of the synapse homolog, transcript variant X5
43 kDa receptor-associated protein of the synapse homolog, transcript variant X7
43 kDa receptor-associated protein of the synapse homolog, transcript variant X6
43 kDa receptor-associated protein of the synapse homolog isoform X7
43 kDa receptor-associated protein of the synapse homolog isoform X5
43 kDa receptor-associated protein of the synapse homolog isoform X4
43 kDa receptor-associated protein of the synapse homolog isoform X3
43 kDa receptor-associated protein of the synapse homolog isoform X2
43 kDa receptor-associated protein of the synapse homolog isoform X1
43 kDa receptor-associated protein of the synapse homolog isoform X6
43 kDa receptor-associated protein of the synapse homolog, transcript variant X8
43 kDa receptor-associated protein of the synapse homolog isoform X8
43 kDa receptor-associated protein of the synapse homolog, transcript variant X9
43 kDa receptor-associated protein of the synapse homolog isoform X9
transcription factor SUM-1, transcript variant X8
transcription factor SUM-1, transcript variant X7
transcription factor SUM-1, transcript variant X1
transcription factor SUM-1, transcript variant X4
transcription factor SUM-1, transcript variant X6
transcription factor SUM-1, transcript variant X5
transcription factor SUM-1, transcript variant X3
transcription factor SUM-1, transcript variant X2
afadin- and alpha-actinin-binding protein-like, transcript variant X1
afadin- and alpha-actinin-binding protein-like, transcript variant X2
afadin- and alpha-actinin-binding protein-like isoform X1
afadin- and alpha-actinin-binding protein-like isoform X2
uncharacterized LOC124949551, transcript variant X2
uncharacterized LOC124949551, transcript variant X1
dynein axonemal intermediate chain 7 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dynein axonemal intermediate chain 7 homolog, transcript variant X2
dynein axonemal intermediate chain 7 homolog, transcript variant X5
dynein axonemal intermediate chain 7 homolog, transcript variant X1
dynein axonemal intermediate chain 7 homolog, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
dynein axonemal intermediate chain 7 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dynein axonemal intermediate chain 7 homolog isoform X5
dynein axonemal intermediate chain 7 homolog isoform X1
dynein axonemal intermediate chain 7 homolog isoform X2
dynein axonemal intermediate chain 7 homolog, transcript variant X6
dynein axonemal intermediate chain 7 homolog isoform X3
dynein axonemal intermediate chain 7 homolog isoform X4
cytochrome b-c1 complex subunit Rieske, mitochondrial-like, transcript variant X1
cytochrome b-c1 complex subunit Rieske, mitochondrial-like, transcript variant X2
cytochrome b-c1 complex subunit Rieske, mitochondrial-like isoform X1
cytochrome b-c1 complex subunit Rieske, mitochondrial-like isoform X2
mediator of RNA polymerase II transcription subunit 11-like
rho guanine nucleotide exchange factor 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC124949250, transcript variant X2
uncharacterized LOC124949250, transcript variant X1
uncharacterized protein LOC124949250 isoform X2
uncharacterized protein LOC124949250 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
serine/threonine-protein kinase MARK2-like, transcript variant X1
serine/threonine-protein kinase MARK2-like, transcript variant X18
serine/threonine-protein kinase MARK2-like, transcript variant X20
serine/threonine-protein kinase MARK2-like, transcript variant X9
serine/threonine-protein kinase MARK2-like, transcript variant X13
serine/threonine-protein kinase MARK2-like, transcript variant X6
serine/threonine-protein kinase MARK2-like, transcript variant X17
serine/threonine-protein kinase MARK2-like, transcript variant X23
serine/threonine-protein kinase MARK2-like, transcript variant X24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
serine/threonine-protein kinase MARK2-like, transcript variant X19
serine/threonine-protein kinase MARK2-like, transcript variant X12
serine/threonine-protein kinase MARK2-like, transcript variant X5
serine/threonine-protein kinase MARK2-like, transcript variant X11
serine/threonine-protein kinase MARK2-like, transcript variant X21
serine/threonine-protein kinase MARK2-like, transcript variant X22
serine/threonine-protein kinase MARK2-like, transcript variant X16
serine/threonine-protein kinase MARK2-like, transcript variant X8
serine/threonine-protein kinase MARK2-like, transcript variant X7
serine/threonine-protein kinase MARK2-like, transcript variant X10
serine/threonine-protein kinase MARK2-like, transcript variant X14
serine/threonine-protein kinase MARK2-like, transcript variant X15
serine/threonine-protein kinase MARK2-like, transcript variant X27
serine/threonine-protein kinase MARK2-like, transcript variant X25
serine/threonine-protein kinase MARK2-like, transcript variant X26
serine/threonine-protein kinase MARK2-like isoform X22
serine/threonine-protein kinase MARK2-like, transcript variant X3
serine/threonine-protein kinase MARK2-like, transcript variant X2
serine/threonine-protein kinase MARK2-like, transcript variant X4
serine/threonine-protein kinase MARK2-like isoform X1
serine/threonine-protein kinase MARK2-like isoform X9
serine/threonine-protein kinase MARK2-like isoform X6
serine/threonine-protein kinase MARK2-like isoform X10
serine/threonine-protein kinase MARK2-like isoform X2
serine/threonine-protein kinase MARK2-like isoform X11
serine/threonine-protein kinase MARK2-like isoform X13
serine/threonine-protein kinase MARK2-like isoform X5
serine/threonine-protein kinase MARK2-like isoform X12
serine/threonine-protein kinase MARK2-like isoform X3
serine/threonine-protein kinase MARK2-like isoform X4
serine/threonine-protein kinase MARK2-like isoform X7
serine/threonine-protein kinase MARK2-like isoform X8
serine/threonine-protein kinase MARK2-like isoform X18
serine/threonine-protein kinase MARK2-like isoform X20
serine/threonine-protein kinase MARK2-like isoform X14
serine/threonine-protein kinase MARK2-like isoform X15
serine/threonine-protein kinase MARK2-like isoform X19
serine/threonine-protein kinase MARK2-like isoform X21
serine/threonine-protein kinase MARK2-like isoform X16
serine/threonine-protein kinase MARK2-like isoform X17
bis(5'-nucleosyl)-tetraphosphatase [asymmetrical], transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
bis(5'-nucleosyl)-tetraphosphatase [asymmetrical], transcript variant X1
bis(5'-nucleosyl)-tetraphosphatase [asymmetrical]
putative elongator complex protein 1, transcript variant X1
putative elongator complex protein 1 isoform X1
putative elongator complex protein 1, transcript variant X2
G2/mitotic-specific cyclin-B, transcript variant X1
G2/mitotic-specific cyclin-B, transcript variant X2
vacuolar protein sorting-associated protein 26C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
vacuolar protein sorting-associated protein 26C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
vacuolar protein sorting-associated protein 26C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
vacuolar protein sorting-associated protein 26C isoform X1
vacuolar protein sorting-associated protein 26C isoform X2
protein-serine O-palmitoleoyltransferase porcupine-like, transcript variant X1
protein-serine O-palmitoleoyltransferase porcupine-like, transcript variant X2
protein-serine O-palmitoleoyltransferase porcupine-like isoform X1
uncharacterized protein LOC124949030 isoform X2
uncharacterized LOC124949032, transcript variant X1
uncharacterized protein LOC124949032 isoform X1
uncharacterized LOC124949032, transcript variant X2
uncharacterized LOC124949032, transcript variant X3
uncharacterized protein LOC124949032 isoform X2
mitochondrial proton/calcium exchanger protein
vacuolar protein sorting-associated protein 13B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
vacuolar protein sorting-associated protein 13B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
vacuolar protein sorting-associated protein 13B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
vacuolar protein sorting-associated protein 13B isoform X1
vacuolar protein sorting-associated protein 13B isoform X2
vacuolar protein sorting-associated protein 13B isoform X3
zinc finger protein 717-like, transcript variant X1
zinc finger protein 717-like, transcript variant X2
zinc finger protein 184-like, transcript variant X1
zinc finger protein 184-like, transcript variant X2
zinc finger protein 184-like, transcript variant X3
zinc finger protein ZFP2-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
rho-related BTB domain-containing protein 1, transcript variant X4
rho-related BTB domain-containing protein 1, transcript variant X6
rho-related BTB domain-containing protein 1, transcript variant X1
rho-related BTB domain-containing protein 1, transcript variant X5
rho-related BTB domain-containing protein 1, transcript variant X2
rho-related BTB domain-containing protein 1, transcript variant X3
rho-related BTB domain-containing protein 1 isoform X1
rho-related BTB domain-containing protein 1 isoform X2
rho-related BTB domain-containing protein 1 isoform X3
rho-related BTB domain-containing protein 2-like, transcript variant X1
rho-related BTB domain-containing protein 2-like, transcript variant X2
rho-related BTB domain-containing protein 2-like isoform X1
rho-related BTB domain-containing protein 2-like isoform X2
H/ACA ribonucleoprotein complex subunit 2-like protein
poly [ADP-ribose] polymerase tankyrase, transcript variant X3
poly [ADP-ribose] polymerase tankyrase, transcript variant X2
poly [ADP-ribose] polymerase tankyrase, transcript variant X1
poly [ADP-ribose] polymerase tankyrase isoform X1
poly [ADP-ribose] polymerase tankyrase isoform X3
poly [ADP-ribose] polymerase tankyrase isoform X2
protein phosphatase 1 regulatory subunit 3B, transcript variant X1
protein phosphatase 1 regulatory subunit 3B, transcript variant X3
protein phosphatase 1 regulatory subunit 3B, transcript variant X2
protein phosphatase 1 regulatory subunit 3C isoform X1
protein phosphatase 1 regulatory subunit 3B isoform X2
serine protease snake-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serine protease snake-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine protease snake-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124949483, transcript variant X1
uncharacterized LOC124949483, transcript variant X2
bifunctional peptidase and (3S)-lysyl hydroxylase Jmjd7, transcript variant X1
bifunctional peptidase and (3S)-lysyl hydroxylase Jmjd7, transcript variant X2
bifunctional peptidase and (3S)-lysyl hydroxylase Jmjd7 isoform X2
bifunctional peptidase and (3S)-lysyl hydroxylase Jmjd7 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
transient receptor potential cation channel trpm, transcript variant X6
transient receptor potential cation channel trpm, transcript variant X8
transient receptor potential cation channel trpm, transcript variant X2
transient receptor potential cation channel trpm, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X4
transient receptor potential cation channel trpm, transcript variant X3
transient receptor potential cation channel trpm, transcript variant X5
transient receptor potential cation channel trpm, transcript variant X12
transient receptor potential cation channel trpm, transcript variant X9
transient receptor potential cation channel trpm, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X10
transient receptor potential cation channel trpm, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X1
transient receptor potential cation channel trpm isoform X5
transient receptor potential cation channel trpm isoform X2
transient receptor potential cation channel trpm isoform X6
transient receptor potential cation channel trpm isoform X3
transient receptor potential cation channel trpm isoform X4
transient receptor potential cation channel trpm isoform X1
elongation factor G, mitochondrial, transcript variant X5
elongation factor G, mitochondrial, transcript variant X2
elongation factor G, mitochondrial, transcript variant X3
elongation factor G, mitochondrial, transcript variant X4
elongation factor G, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon UAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
integrin beta pat-3-like, transcript variant X1
integrin beta pat-3-like, transcript variant X2
integrin beta pat-3-like, transcript variant X3
integrin beta pat-3-like, transcript variant X4
mothers against decapentaplegic homolog 3, transcript variant X1
mothers against decapentaplegic homolog 3, transcript variant X2
mothers against decapentaplegic homolog 3 isoform X1
mothers against decapentaplegic homolog 3 isoform X2
serine/arginine repetitive matrix protein 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
serine/arginine repetitive matrix protein 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
serine/arginine repetitive matrix protein 5 isoform X1
serine/arginine repetitive matrix protein 5 isoform X2
putative tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase
probable U3 small nucleolar RNA-associated protein 11, transcript variant X1
probable U3 small nucleolar RNA-associated protein 11, transcript variant X3
probable U3 small nucleolar RNA-associated protein 11, transcript variant X2
probable U3 small nucleolar RNA-associated protein 11, transcript variant X4
probable U3 small nucleolar RNA-associated protein 11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 86% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: calcium-binding protein P-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
putative surface protein SACOL0050, transcript variant X2
putative surface protein SACOL0050, transcript variant X1
putative surface protein SACOL0050, transcript variant X3
probable serine/threonine-protein kinase cdc7, transcript variant X2
probable serine/threonine-protein kinase cdc7, transcript variant X1
probable serine/threonine-protein kinase cdc7
glutamate receptor 3-like, transcript variant X2
glutamate receptor 3-like, transcript variant X1
uncharacterized protein LOC124949222 isoform X2
glutamate receptor ionotropic, delta-2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29% coverage of the annotated genomic feature by RNAseq alignments
glutamate receptor ionotropic, delta-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52% coverage of the annotated genomic feature by RNAseq alignments
glutamate receptor ionotropic, kainate glr-3-like
uncharacterized LOC124949314, transcript variant X2
uncharacterized LOC124949314, transcript variant X4
uncharacterized LOC124949314, transcript variant X1
uncharacterized LOC124949314, transcript variant X3
uncharacterized LOC124949314, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ring canal kelch homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ring canal kelch homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ring canal kelch homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cyclic nucleotide-gated channel cone photoreceptor subunit alpha-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
NCK-interacting protein with SH3 domain, transcript variant X4
translocon-associated protein subunit gamma-like, transcript variant X1
uncharacterized protein LOC124949294 isoform X1
translocon-associated protein subunit gamma-like, transcript variant X2
translocon-associated protein subunit gamma-like, transcript variant X3
uncharacterized protein LOC124949294 isoform X2
NCK-interacting protein with SH3 domain, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
translocon-associated protein subunit gamma-like, transcript variant X4
translocon-associated protein subunit gamma-like isoform X3
troponin C, isoallergen Bla g 6.0301, transcript variant X1
troponin C, isoallergen Bla g 6.0301, transcript variant X2
troponin C, isoallergen Bla g 6.0301 isoform X1
troponin C, isoallergen Bla g 6.0301 isoform X2
NCK-interacting protein with SH3 domain, transcript variant X2
NCK-interacting protein with SH3 domain, transcript variant X1
transcription initiation factor TFIID subunit 5, transcript variant X2
transcription initiation factor TFIID subunit 5, transcript variant X1
transcription initiation factor TFIID subunit 5 isoform X2
transcription initiation factor TFIID subunit 5 isoform X1
zinc finger protein 836-like, transcript variant X5
zinc finger protein 836-like, transcript variant X3
zinc finger protein 836-like, transcript variant X1
zinc finger protein 836-like, transcript variant X2
zinc finger protein 836-like, transcript variant X4
zinc finger protein 836-like, transcript variant X7
zinc finger protein 836-like, transcript variant X6
uncharacterized LOC124949540, transcript variant X1
uncharacterized LOC124949540, transcript variant X2
uncharacterized LOC124949536, transcript variant X6
uncharacterized LOC124949536, transcript variant X3
uncharacterized LOC124949536, transcript variant X4
uncharacterized LOC124949536, transcript variant X2
uncharacterized LOC124949536, transcript variant X5
uncharacterized LOC124949536, transcript variant X8
uncharacterized LOC124949536, transcript variant X7
uncharacterized LOC124949536, transcript variant X1
uncharacterized LOC124949536, transcript variant X9
uncharacterized protein LOC124949536 isoform X3
uncharacterized protein LOC124949536 isoform X2
uncharacterized protein LOC124949536 isoform X1
uncharacterized protein LOC124949536 isoform X4
hippocampus abundant transcript 1 protein, transcript variant X2
hippocampus abundant transcript 1 protein isoform X2
hippocampus abundant transcript 1 protein, transcript variant X1
hippocampus abundant transcript 1 protein, transcript variant X3
hippocampus abundant transcript 1 protein isoform X1
hippocampus abundant transcript 1 protein isoform X3
centrosomal protein of 120 kDa, transcript variant X1
centrosomal protein of 120 kDa, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
centrosomal protein of 120 kDa isoform X2
centrosomal protein of 120 kDa isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X5
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X1
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X8
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X9
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X4
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X1
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X2
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X5
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X4
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X7
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X3
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X7
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X6
tyrosine-protein phosphatase 99A, transcript variant X3
tyrosine-protein phosphatase 99A isoform X3
tyrosine-protein phosphatase 99A, transcript variant X2
tyrosine-protein phosphatase 99A, transcript variant X1
tyrosine-protein phosphatase 99A, transcript variant X10
tyrosine-protein phosphatase 99A, transcript variant X6
tyrosine-protein phosphatase 99A, transcript variant X5
tyrosine-protein phosphatase 99A, transcript variant X4
tyrosine-protein phosphatase 99A, transcript variant X9
tyrosine-protein phosphatase 99A, transcript variant X7
tyrosine-protein phosphatase 99A, transcript variant X8
tyrosine-protein phosphatase 99A isoform X2
tyrosine-protein phosphatase 99A isoform X1
tyrosine-protein phosphatase 99A isoform X5
tyrosine-protein phosphatase 99A isoform X4
uncharacterized LOC124949040, transcript variant X2
uncharacterized LOC124949040, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
cx9C motif-containing protein 4, transcript variant X2
cx9C motif-containing protein 4, transcript variant X1
irregular chiasm C-roughest protein-like, transcript variant X6
irregular chiasm C-roughest protein-like, transcript variant X5
irregular chiasm C-roughest protein-like, transcript variant X4
irregular chiasm C-roughest protein-like, transcript variant X8
irregular chiasm C-roughest protein-like, transcript variant X7
irregular chiasm C-roughest protein-like, transcript variant X2
irregular chiasm C-roughest protein-like, transcript variant X3
irregular chiasm C-roughest protein-like, transcript variant X1
irregular chiasm C-roughest protein-like, transcript variant X9
irregular chiasm C-roughest protein-like isoform X4
irregular chiasm C-roughest protein-like isoform X5
irregular chiasm C-roughest protein-like isoform X6
irregular chiasm C-roughest protein-like isoform X3
irregular chiasm C-roughest protein-like isoform X2
irregular chiasm C-roughest protein-like isoform X1
irregular chiasm C-roughest protein-like isoform X7
retinoblastoma-binding protein 5 homolog, transcript variant X3
retinoblastoma-binding protein 5 homolog, transcript variant X2
retinoblastoma-binding protein 5 homolog, transcript variant X1
retinoblastoma-binding protein 5 homolog isoform X2
retinoblastoma-binding protein 5 homolog isoform X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X2
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X3
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X7
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X5
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X4
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X6
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like isoform X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like isoform X2
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like isoform X4
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like isoform X3
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like isoform X5
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like isoform X6
dynein axonemal light chain 1-like, transcript variant X1
dynein axonemal light chain 1-like, transcript variant X2
dynein axonemal light chain 1-like, transcript variant X9
dynein axonemal light chain 1-like, transcript variant X8
dynein axonemal light chain 1-like isoform X3
dynein axonemal light chain 1-like isoform X4
dynein axonemal light chain 1-like isoform X1
dynein axonemal light chain 1-like, transcript variant X7
dynein axonemal light chain 1-like, transcript variant X5
dynein axonemal light chain 1-like, transcript variant X6
dynein axonemal light chain 1-like, transcript variant X3
dynein axonemal light chain 1-like, transcript variant X4
dynein axonemal light chain 1-like isoform X2
DNA polymerase epsilon subunit 2, transcript variant X3
DNA polymerase epsilon subunit 2 isoform X3
DNA polymerase epsilon subunit 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
DNA polymerase epsilon subunit 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
DNA polymerase epsilon subunit 2 isoform X1
DNA polymerase epsilon subunit 2 isoform X2
uncharacterized LOC124949450, transcript variant X2
uncharacterized LOC124949450, transcript variant X1
uncharacterized protein LOC124949450 isoform X2
uncharacterized protein LOC124949450 isoform X1
nucleolar protein of 40 kDa-like, transcript variant X2
nucleolar protein of 40 kDa-like, transcript variant X1
26S proteasome non-ATPase regulatory subunit 9, transcript variant X2
26S proteasome non-ATPase regulatory subunit 9, transcript variant X3
26S proteasome non-ATPase regulatory subunit 9, transcript variant X4
26S proteasome non-ATPase regulatory subunit 9, transcript variant X1
26S proteasome non-ATPase regulatory subunit 9 isoform X2
26S proteasome non-ATPase regulatory subunit 9 isoform X1
intracellular protein transport protein USO1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 41% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
elongation of very long chain fatty acids protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
elongation of very long chain fatty acids protein 1-like isoform X1
elongation of very long chain fatty acids protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
elongation of very long chain fatty acids protein 1-like isoform X2
cysteine sulfinic acid decarboxylase-like
protein UXT homolog, transcript variant X2
protein UXT homolog, transcript variant X1
uncharacterized LOC124949500, transcript variant X8
uncharacterized LOC124949500, transcript variant X3
uncharacterized LOC124949500, transcript variant X2
uncharacterized LOC124949500, transcript variant X7
uncharacterized LOC124949500, transcript variant X9
uncharacterized LOC124949500, transcript variant X1
uncharacterized LOC124949500, transcript variant X6
uncharacterized LOC124949500, transcript variant X5
uncharacterized LOC124949500, transcript variant X4
uncharacterized protein LOC124949500 isoform X2
uncharacterized protein LOC124949500 isoform X1
uncharacterized LOC124949500, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC124949500, transcript variant X10
uncharacterized protein LOC124949500 isoform X3
uncharacterized LOC124949500, transcript variant X11
uncharacterized LOC124949500, transcript variant X13
uncharacterized protein LOC124949500 isoform X4
homeobox protein prospero-like, transcript variant X3
homeobox protein prospero-like, transcript variant X1
homeobox protein prospero-like, transcript variant X2
homeobox protein prospero-like isoform X3
homeobox protein prospero-like isoform X2
homeobox protein prospero-like isoform X1
uncharacterized protein DDB_G0286105-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein DDB_G0286105-like, transcript variant X1
uncharacterized protein DDB_G0286105-like, transcript variant X2
uncharacterized protein DDB_G0286105-like, transcript variant X3
uncharacterized protein DDB_G0286105-like
omega-conotoxin-like protein 1, transcript variant X2
omega-conotoxin-like protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins
probable methyltransferase-like protein 15 homolog, transcript variant X2
probable methyltransferase-like protein 15 homolog, transcript variant X1
C-1-tetrahydrofolate synthase, cytoplasmic, transcript variant X1
C-1-tetrahydrofolate synthase, cytoplasmic isoform X1
C-1-tetrahydrofolate synthase, cytoplasmic, transcript variant X2
C-1-tetrahydrofolate synthase, cytoplasmic isoform X2
C-1-tetrahydrofolate synthase, cytoplasmic, transcript variant X3
C-1-tetrahydrofolate synthase, cytoplasmic, transcript variant X4
C-1-tetrahydrofolate synthase, cytoplasmic isoform X3
C-1-tetrahydrofolate synthase, cytoplasmic isoform X4
probable methyltransferase-like protein 15 homolog, transcript variant X3
probable methyltransferase-like protein 15 homolog
ubiquinol-cytochrome-c reductase complex assembly factor 2
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00286
choline-phosphate cytidylyltransferase A-like, transcript variant X6
choline-phosphate cytidylyltransferase A-like, transcript variant X2
choline-phosphate cytidylyltransferase A-like, transcript variant X1
choline-phosphate cytidylyltransferase A-like, transcript variant X4
choline-phosphate cytidylyltransferase A-like, transcript variant X5
choline-phosphate cytidylyltransferase A-like, transcript variant X3
choline-phosphate cytidylyltransferase A-like, transcript variant X7
choline-phosphate cytidylyltransferase A-like isoform X1
choline-phosphate cytidylyltransferase A-like isoform X2
uncharacterized LOC124949465, transcript variant X3
uncharacterized LOC124949465, transcript variant X2
uncharacterized LOC124949465, transcript variant X1
uncharacterized LOC124949465, transcript variant X5
uncharacterized LOC124949465, transcript variant X6
uncharacterized LOC124949465, transcript variant X7
uncharacterized LOC124949465, transcript variant X4
uncharacterized LOC124949465, transcript variant X8
uncharacterized protein LOC124949465 isoform X1
uncharacterized protein LOC124949465 isoform X2
uncharacterized protein LOC124949465 isoform X3
uncharacterized protein LOC124949465 isoform X4
uncharacterized LOC124949465, transcript variant X9
myosin regulatory light chain sqh-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
myosin regulatory light chain sqh-like, transcript variant X1
myosin regulatory light chain sqh-like isoform X1
myosin regulatory light chain RLC-A-like isoform X2
pyridoxal phosphate homeostasis protein, transcript variant X2
pyridoxal phosphate homeostasis protein, transcript variant X1
pyridoxal phosphate homeostasis protein isoform X2
pyridoxal phosphate homeostasis protein isoform X1
signal recognition particle 54 kDa protein
protein spindle-F, transcript variant X4
protein spindle-F, transcript variant X9
protein spindle-F, transcript variant X10
protein spindle-F, transcript variant X2
protein spindle-F, transcript variant X6
protein spindle-F, transcript variant X5
protein spindle-F, transcript variant X7
protein spindle-F, transcript variant X8
protein spindle-F, transcript variant X1
protein spindle-F, transcript variant X3
39S ribosomal protein L32, mitochondrial
N6-adenosine-methyltransferase subunit METTL3
rho guanine nucleotide exchange factor 3-like, transcript variant X2
rho guanine nucleotide exchange factor 3-like, transcript variant X1
rho guanine nucleotide exchange factor 3-like, transcript variant X3
rho guanine nucleotide exchange factor 3-like isoform X1
rho guanine nucleotide exchange factor 3-like isoform X2
CWF19-like protein 1, transcript variant X2
CWF19-like protein 1, transcript variant X3
CWF19-like protein 1, transcript variant X4
CWF19-like protein 1, transcript variant X1
probable methylthioribulose-1-phosphate dehydratase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
probable methylthioribulose-1-phosphate dehydratase, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
probable methylthioribulose-1-phosphate dehydratase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
probable methylthioribulose-1-phosphate dehydratase, transcript variant X5
probable methylthioribulose-1-phosphate dehydratase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
probable methylthioribulose-1-phosphate dehydratase, transcript variant X2
probable methylthioribulose-1-phosphate dehydratase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
probable methylthioribulose-1-phosphate dehydratase
COMM domain-containing protein 10-like, transcript variant X3
COMM domain-containing protein 10-like, transcript variant X1
COMM domain-containing protein 10-like, transcript variant X5
COMM domain-containing protein 10-like, transcript variant X4
COMM domain-containing protein 10-like, transcript variant X2
COMM domain-containing protein 10-like isoform X3
COMM domain-containing protein 10-like isoform X1
COMM domain-containing protein 10-like isoform X2
uncharacterized LOC124949210, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC124949210, transcript variant X1
uncharacterized protein LOC124949210 isoform X1
uncharacterized protein LOC124949210 isoform X2
ankyrin repeat domain-containing protein 16-like
latrophilin Cirl-like, transcript variant X11
latrophilin Cirl-like, transcript variant X6
latrophilin Cirl-like, transcript variant X5
latrophilin Cirl-like, transcript variant X2
latrophilin Cirl-like, transcript variant X7
latrophilin Cirl-like, transcript variant X1
latrophilin Cirl-like, transcript variant X8
latrophilin Cirl-like, transcript variant X4
latrophilin Cirl-like, transcript variant X3
latrophilin Cirl-like, transcript variant X10
latrophilin Cirl-like, transcript variant X15
latrophilin Cirl-like, transcript variant X14
latrophilin Cirl-like, transcript variant X13
latrophilin Cirl-like, transcript variant X16
latrophilin Cirl-like, transcript variant X12
latrophilin Cirl-like, transcript variant X9
latrophilin Cirl-like, transcript variant X17
latrophilin Cirl-like, transcript variant X18
latrophilin Cirl-like, transcript variant X19
latrophilin Cirl-like, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC124949217, transcript variant X2
uncharacterized LOC124949217, transcript variant X1
mitochondrial import inner membrane translocase subunit TIM50-C-like
phosphatidylinositol 3-kinase regulatory subunit alpha, transcript variant X5
phosphatidylinositol 3-kinase regulatory subunit alpha, transcript variant X3
phosphatidylinositol 3-kinase regulatory subunit alpha, transcript variant X4
phosphatidylinositol 3-kinase regulatory subunit alpha isoform X2
phosphatidylinositol 3-kinase regulatory subunit alpha, transcript variant X1
phosphatidylinositol 3-kinase regulatory subunit alpha, transcript variant X2
uncharacterized protein LOC124949563 isoform X1
uncharacterized LOC124949534, transcript variant X1
uncharacterized LOC124949534, transcript variant X2
uncharacterized protein LOC124949534 isoform X2
uncharacterized protein LOC124949534 isoform X1
uncharacterized LOC124949535, transcript variant X2
uncharacterized LOC124949535, transcript variant X1
glycine receptor subunit alpha-2, transcript variant X1
glycine receptor subunit alpha-2, transcript variant X2
glycine receptor subunit alpha-2, transcript variant X3
glycine receptor subunit alpha-2, transcript variant X4
glycine receptor subunit alpha-4 isoform X1
glycine receptor subunit alpha-4 isoform X2
glycine receptor subunit alpha-2 isoform X3
potassium voltage-gated channel protein Shal, transcript variant X8
potassium voltage-gated channel protein Shal isoform X6
potassium voltage-gated channel protein Shal, transcript variant X5
potassium voltage-gated channel protein Shal, transcript variant X3
potassium voltage-gated channel protein Shal, transcript variant X1
potassium voltage-gated channel protein Shal, transcript variant X4
potassium voltage-gated channel protein Shal, transcript variant X6
potassium voltage-gated channel protein Shal, transcript variant X2
potassium voltage-gated channel protein Shal isoform X4
potassium voltage-gated channel protein Shal isoform X1
potassium voltage-gated channel protein Shal isoform X2
potassium voltage-gated channel protein Shal isoform X3
potassium voltage-gated channel protein Shal, transcript variant X7
potassium voltage-gated channel protein Shal isoform X5
uncharacterized LOC124949086, transcript variant X2
uncharacterized LOC124949086, transcript variant X3
uncharacterized LOC124949086, transcript variant X1
rho GTPase-activating protein 190, transcript variant X2
rho GTPase-activating protein 190, transcript variant X3
rho GTPase-activating protein 190, transcript variant X1
rho GTPase-activating protein 190 isoform X2
rho GTPase-activating protein 190 isoform X3
rho GTPase-activating protein 190 isoform X1
adenosylhomocysteinase-like 1, transcript variant X3
adenosylhomocysteinase-like 1, transcript variant X5
adenosylhomocysteinase-like 1, transcript variant X1
adenosylhomocysteinase-like 1, transcript variant X2
adenosylhomocysteinase-like 1 isoform X1
adenosylhomocysteinase-like 1 isoform X2
adenosylhomocysteinase-like 1 isoform X3
adenosylhomocysteinase-like 1 isoform X5
adenosylhomocysteinase-like 1, transcript variant X4
adenosylhomocysteinase-like 1 isoform X4
uncharacterized LOC124949076, transcript variant X1
uncharacterized LOC124949076, transcript variant X4
uncharacterized LOC124949076, transcript variant X2
uncharacterized LOC124949076, transcript variant X3
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like, transcript variant X2
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like, transcript variant X4
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like, transcript variant X3
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like, transcript variant X1
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2-like isoform X3
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like isoform X2
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like isoform X1
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like, transcript variant X5
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like isoform X4
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial isoform X2
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial isoform X1
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial isoform X4
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial isoform X3
ankyrin repeat and zinc finger domain-containing protein 1-like, transcript variant X3
ankyrin repeat and zinc finger domain-containing protein 1-like, transcript variant X2
ankyrin repeat and zinc finger domain-containing protein 1-like, transcript variant X1
ankyrin repeat and zinc finger domain-containing protein 1-like isoform X1
ankyrin repeat and zinc finger domain-containing protein 1-like isoform X2
RNA polymerase I-specific transcription initiation factor RRN3, transcript variant X3
RNA polymerase I-specific transcription initiation factor RRN3, transcript variant X1
RNA polymerase I-specific transcription initiation factor RRN3, transcript variant X2
RNA polymerase I-specific transcription initiation factor RRN3 isoform X2
RNA polymerase I-specific transcription initiation factor RRN3 isoform X1
dynein axonemal heavy chain 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dynein axonemal heavy chain 8, transcript variant X5
dynein axonemal heavy chain 8, transcript variant X1
dynein axonemal heavy chain 8, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dynein axonemal heavy chain 8, transcript variant X7
dynein axonemal heavy chain 8, transcript variant X6
dynein axonemal heavy chain 8, transcript variant X2
dynein axonemal heavy chain 8, transcript variant X10
dynein axonemal heavy chain 8, transcript variant X11
dynein axonemal heavy chain 8 isoform X1
dynein axonemal heavy chain 8 isoform X3
dynein axonemal heavy chain 8 isoform X5
dynein axonemal heavy chain 8 isoform X8
dynein axonemal heavy chain 8 isoform X7
dynein axonemal heavy chain 8 isoform X6
dynein axonemal heavy chain 8 isoform X2
dynein axonemal heavy chain 8 isoform X10
dynein axonemal heavy chain 8 isoform X11
dynein axonemal heavy chain 8, transcript variant X4
diacylglycerol lipase-beta-like, transcript variant X8
diacylglycerol lipase-beta-like, transcript variant X2
diacylglycerol lipase-beta-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
diacylglycerol lipase-beta-like, transcript variant X3
diacylglycerol lipase-beta-like, transcript variant X6
diacylglycerol lipase-beta-like, transcript variant X7
diacylglycerol lipase-beta-like, transcript variant X5
diacylglycerol lipase-beta-like, transcript variant X4
diacylglycerol lipase-beta-like isoform X4
diacylglycerol lipase-beta-like isoform X2
diacylglycerol lipase-beta-like isoform X1
diacylglycerol lipase-beta-like isoform X3
dynein axonemal heavy chain 8 isoform X4
dynein axonemal heavy chain 8, transcript variant X9
dynein axonemal heavy chain 8 isoform X9
dynein axonemal heavy chain 8, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dynein axonemal heavy chain 8 isoform X12
V-set and immunoglobulin domain-containing protein 2-like, transcript variant X2
V-set and immunoglobulin domain-containing protein 2-like, transcript variant X5
V-set and immunoglobulin domain-containing protein 2-like, transcript variant X4
V-set and immunoglobulin domain-containing protein 2-like, transcript variant X3
V-set and immunoglobulin domain-containing protein 2-like, transcript variant X1
V-set and immunoglobulin domain-containing protein 2-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
V-set and immunoglobulin domain-containing protein 2-like, transcript variant X6
uncharacterized protein LOC124949310 isoform X2
V-set and immunoglobulin domain-containing protein 2-like isoform X5
uncharacterized protein LOC124949310 isoform X4
uncharacterized protein LOC124949310 isoform X3
uncharacterized protein LOC124949310 isoform X1
uncharacterized protein LOC124949310 isoform X7
uncharacterized protein LOC124949310 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124949304, transcript variant X4
uncharacterized LOC124949304, transcript variant X2
uncharacterized LOC124949304, transcript variant X3
uncharacterized LOC124949304, transcript variant X1
uncharacterized protein LOC124949304 isoform X2
uncharacterized protein LOC124949304 isoform X1
uncharacterized LOC124949311, transcript variant X3
uncharacterized LOC124949311, transcript variant X6
uncharacterized LOC124949311, transcript variant X1
uncharacterized LOC124949311, transcript variant X4
uncharacterized LOC124949311, transcript variant X2
uncharacterized LOC124949311, transcript variant X7
uncharacterized LOC124949311, transcript variant X5
coiled-coil domain-containing protein 142
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Fanconi anemia group M protein homolog, transcript variant X1
Fanconi anemia group M protein homolog, transcript variant X2
Fanconi anemia group M protein homolog, transcript variant X3
Fanconi anemia group M protein homolog isoform X1
Fanconi anemia group M protein isoform X2
Fanconi anemia group M protein isoform X3
5'-3' exonuclease PLD3-like, transcript variant X4
5'-3' exonuclease PLD3-like, transcript variant X2
5'-3' exonuclease PLD3-like, transcript variant X3
5'-3' exonuclease PLD3-like, transcript variant X6
5'-3' exonuclease PLD3-like, transcript variant X1
5'-3' exonuclease PLD3-like, transcript variant X5
AF4/FMR2 family member lilli-like, transcript variant X9
AF4/FMR2 family member lilli-like, transcript variant X1
AF4/FMR2 family member lilli-like, transcript variant X10
AF4/FMR2 family member lilli-like, transcript variant X3
AF4/FMR2 family member lilli-like, transcript variant X6
AF4/FMR2 family member lilli-like, transcript variant X8
AF4/FMR2 family member lilli-like, transcript variant X7
AF4/FMR2 family member lilli-like, transcript variant X2
AF4/FMR2 family member lilli-like, transcript variant X5
AF4/FMR2 family member lilli-like, transcript variant X4
uncharacterized protein LOC124949508 isoform X3
uncharacterized protein LOC124949508 isoform X1
AF4/FMR2 family member lilli-like isoform X2
methylmalonic aciduria and homocystinuria type D homolog, mitochondrial, transcript variant X4
methylmalonic aciduria and homocystinuria type D homolog, mitochondrial, transcript variant X3
methylmalonic aciduria and homocystinuria type D homolog, mitochondrial, transcript variant X2
methylmalonic aciduria and homocystinuria type D homolog, mitochondrial, transcript variant X1
methylmalonic aciduria and homocystinuria type D homolog, mitochondrial isoform X1
methylmalonic aciduria and homocystinuria type D homolog, mitochondrial, transcript variant X5
methylmalonic aciduria and homocystinuria type D homolog, mitochondrial isoform X2
protein diaphanous, transcript variant X6
protein diaphanous, transcript variant X5
protein diaphanous, transcript variant X3
protein diaphanous, transcript variant X1
protein diaphanous, transcript variant X4
protein diaphanous, transcript variant X2
general transcription factor IIH subunit 4, transcript variant X2
general transcription factor IIH subunit 4, transcript variant X3
general transcription factor IIH subunit 4, transcript variant X1
general transcription factor IIH subunit 4 isoform X1
general transcription factor IIH subunit 4 isoform X2
general transcription factor IIH subunit 4 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
adrenodoxin-like protein 1, mitochondrial, transcript variant X1
adrenodoxin-like protein 1, mitochondrial, transcript variant X2
adrenodoxin-like protein 1, mitochondrial isoform X1
adrenodoxin-like protein 1, mitochondrial isoform X2
sprouty-related, EVH1 domain-containing protein 1, transcript variant X3
sprouty-related, EVH1 domain-containing protein 1, transcript variant X9
sprouty-related, EVH1 domain-containing protein 1, transcript variant X8
sprouty-related, EVH1 domain-containing protein 1, transcript variant X6
sprouty-related, EVH1 domain-containing protein 1, transcript variant X4
sprouty-related, EVH1 domain-containing protein 1, transcript variant X5
sprouty-related, EVH1 domain-containing protein 1, transcript variant X2
sprouty-related, EVH1 domain-containing protein 1, transcript variant X1
sprouty-related, EVH1 domain-containing protein 1, transcript variant X7
sprouty-related, EVH1 domain-containing protein 1 isoform X7
sprouty-related, EVH1 domain-containing protein 3 isoform X6
sprouty-related, EVH1 domain-containing protein 2 isoform X4
sprouty-related, EVH1 domain-containing protein 1 isoform X3
sprouty-related, EVH1 domain-containing protein 3 isoform X2
sprouty-related, EVH1 domain-containing protein 2 isoform X1
sprouty-related, EVH1 domain-containing protein 1 isoform X5
nuclear receptor coactivator 6, transcript variant X1
nuclear receptor coactivator 6, transcript variant X2
uncharacterized protein LOC124949181 isoform X1
nuclear receptor coactivator 6 isoform X2
multiple C2 and transmembrane domain-containing protein, transcript variant X10
multiple C2 and transmembrane domain-containing protein, transcript variant X1
multiple C2 and transmembrane domain-containing protein, transcript variant X5
multiple C2 and transmembrane domain-containing protein, transcript variant X6
multiple C2 and transmembrane domain-containing protein, transcript variant X4
multiple C2 and transmembrane domain-containing protein, transcript variant X2
multiple C2 and transmembrane domain-containing protein, transcript variant X3
multiple C2 and transmembrane domain-containing protein isoform X1
multiple C2 and transmembrane domain-containing protein isoform X2
multiple C2 and transmembrane domain-containing protein isoform X4
multiple C2 and transmembrane domain-containing protein isoform X3
multiple C2 and transmembrane domain-containing protein isoform X9
multiple C2 and transmembrane domain-containing protein, transcript variant X8
multiple C2 and transmembrane domain-containing protein, transcript variant X7
multiple C2 and transmembrane domain-containing protein isoform X6
multiple C2 and transmembrane domain-containing protein isoform X5
multiple C2 and transmembrane domain-containing protein isoform X7
multiple C2 and transmembrane domain-containing protein, transcript variant X11
multiple C2 and transmembrane domain-containing protein isoform X10
multiple C2 and transmembrane domain-containing protein, transcript variant X9
multiple C2 and transmembrane domain-containing protein isoform X8
NADH-quinone oxidoreductase subunit B-like
MAU2 chromatid cohesion factor homolog, transcript variant X2
MAU2 chromatid cohesion factor homolog, transcript variant X1
transcriptional repressor p66-beta-like, transcript variant X4
transcriptional repressor p66-beta-like, transcript variant X8
transcriptional repressor p66-beta-like, transcript variant X10
transcriptional repressor p66-beta-like isoform X5
transcriptional repressor p66-beta-like isoform X7
transcriptional repressor p66-beta-like, transcript variant X5
transcriptional repressor p66-beta-like, transcript variant X6
transcriptional repressor p66-beta-like, transcript variant X12
transcriptional repressor p66-beta-like, transcript variant X15
transcriptional repressor p66-beta-like, transcript variant X7
transcriptional repressor p66-beta-like isoform X3
transcriptional repressor p66-beta-like isoform X4
transcriptional repressor p66-beta-like, transcript variant X13
transcriptional repressor p66-beta-like, transcript variant X14
transcriptional repressor p66-beta-like, transcript variant X16
transcriptional repressor p66-beta-like, transcript variant X3
transcriptional repressor p66-beta-like, transcript variant X1
transcriptional repressor p66-beta-like, transcript variant X2
transcriptional repressor p66-beta-like, transcript variant X17
transcriptional repressor p66-beta-like, transcript variant X9
transcriptional repressor p66-beta-like, transcript variant X11
transcriptional repressor p66-beta-like isoform X1
transcriptional repressor p66-beta-like isoform X11
transcriptional repressor p66-beta-like isoform X6
transcriptional repressor p66-beta-like isoform X2
transcriptional repressor p66-beta-like isoform X8
transcriptional repressor p66-beta-like isoform X9
transcriptional repressor p66-beta-like isoform X10
uncharacterized LOC124949158, transcript variant X1
uncharacterized LOC124949158, transcript variant X3
uncharacterized LOC124949158, transcript variant X2
uncharacterized LOC124949152, transcript variant X2
uncharacterized LOC124949152, transcript variant X1
uncharacterized protein LOC124949152 isoform X1
uncharacterized LOC124949152, transcript variant X3
uncharacterized LOC124949152, transcript variant X4
uncharacterized protein LOC124949152 isoform X2
protein prickle-like, transcript variant X4
protein prickle-like, transcript variant X5
protein prickle-like, transcript variant X3
protein prickle-like, transcript variant X6
protein prickle-like, transcript variant X2
protein prickle-like, transcript variant X1
prickle planar cell polarity protein 3-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
PX domain-containing protein kinase-like protein, transcript variant X1
PX domain-containing protein kinase-like protein isoform X1
PX domain-containing protein kinase-like protein, transcript variant X2
PX domain-containing protein kinase-like protein isoform X2
eukaryotic translation initiation factor 2D, transcript variant X2
eukaryotic translation initiation factor 2D, transcript variant X1
eukaryotic translation initiation factor 2D isoform X1
eukaryotic translation initiation factor 2D isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ELAV-like protein 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ELAV-like protein 2, transcript variant X3
ELAV-like protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ELAV-like protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ELAV-like protein 2, transcript variant X2
ELAV-like protein 2, transcript variant X1
cytosolic carboxypeptidase 6, transcript variant X2
cytosolic carboxypeptidase 6, transcript variant X1
RNA-binding protein 5-like, transcript variant X1
RNA-binding protein 5-like, transcript variant X2
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like, transcript variant X2
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like, transcript variant X1
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like isoform X1
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like isoform X2
5-aminolevulinate synthase, erythroid-specific, mitochondrial, transcript variant X2
5-aminolevulinate synthase, erythroid-specific, mitochondrial, transcript variant X1
5-aminolevulinate synthase, erythroid-specific, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 234 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 236 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 522 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 73 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
histone-lysine N-methyltransferase SETMAR-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 228 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 345 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 84 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X6
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X7
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X2
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X4
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X5
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X8
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X1
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X3
gamma-aminobutyric acid type B receptor subunit 2 isoform X3
gamma-aminobutyric acid type B receptor subunit 2 isoform X4
gamma-aminobutyric acid type B receptor subunit 2 isoform X2
gamma-aminobutyric acid type B receptor subunit 2 isoform X5
gamma-aminobutyric acid type B receptor subunit 2 isoform X1
RING finger and CHY zinc finger domain-containing protein 1, transcript variant X2
RING finger and CHY zinc finger domain-containing protein 1, transcript variant X1
RING finger and CHY zinc finger domain-containing protein 1
transcriptional activator Myb, transcript variant X5
transcriptional activator Myb, transcript variant X6
transcriptional activator Myb, transcript variant X4
transcriptional activator Myb, transcript variant X3
transcriptional activator Myb, transcript variant X1
transcriptional activator Myb, transcript variant X2
transcriptional activator Myb isoform X4
mediator of RNA polymerase II transcription subunit 27-like, transcript variant X2
mediator of RNA polymerase II transcription subunit 27-like, transcript variant X4
mediator of RNA polymerase II transcription subunit 27-like, transcript variant X1
mediator of RNA polymerase II transcription subunit 27-like, transcript variant X3
mediator of RNA polymerase II transcription subunit 27-like
uncharacterized protein LOC124949556 isoform X1
probable serine/threonine-protein kinase DDB_G0282963, transcript variant X2
probable serine/threonine-protein kinase DDB_G0282963, transcript variant X3
probable serine/threonine-protein kinase DDB_G0282963, transcript variant X4
probable serine/threonine-protein kinase DDB_G0282963, transcript variant X1
uncharacterized protein LOC124949067 isoform X1
probable serine/threonine-protein kinase DDB_G0282963 isoform X3
uncharacterized protein LOC124949067 isoform X2
probable serine/threonine-protein kinase DDB_G0282963, transcript variant X5
probable serine/threonine-protein kinase DDB_G0282963 isoform X4
mitochondrial dimethyladenosine transferase 1
cytochrome c oxidase assembly factor 3, mitochondrial
regulating synaptic membrane exocytosis protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
regulating synaptic membrane exocytosis protein 1, transcript variant X4
regulating synaptic membrane exocytosis protein 1, transcript variant X1
regulating synaptic membrane exocytosis protein 1, transcript variant X7
regulating synaptic membrane exocytosis protein 1, transcript variant X8
regulating synaptic membrane exocytosis protein 1, transcript variant X5
regulating synaptic membrane exocytosis protein 1, transcript variant X6
regulating synaptic membrane exocytosis protein 1, transcript variant X2
regulating synaptic membrane exocytosis protein 1, transcript variant X11
regulating synaptic membrane exocytosis protein 1, transcript variant X16
regulating synaptic membrane exocytosis protein 1, transcript variant X17
regulating synaptic membrane exocytosis protein 1, transcript variant X10
regulating synaptic membrane exocytosis protein 1, transcript variant X14
regulating synaptic membrane exocytosis protein 1, transcript variant X15
regulating synaptic membrane exocytosis protein 1, transcript variant X9
regulating synaptic membrane exocytosis protein 1, transcript variant X12
regulating synaptic membrane exocytosis protein 1, transcript variant X13
regulating synaptic membrane exocytosis protein 1 isoform X1
regulating synaptic membrane exocytosis protein 1 isoform X4
regulating synaptic membrane exocytosis protein 1 isoform X5
regulating synaptic membrane exocytosis protein 1 isoform X2
regulating synaptic membrane exocytosis protein 1 isoform X3
regulating synaptic membrane exocytosis protein 1 isoform X12
regulating synaptic membrane exocytosis protein 1 isoform X13
regulating synaptic membrane exocytosis protein 1 isoform X7
regulating synaptic membrane exocytosis protein 1 isoform X10
regulating synaptic membrane exocytosis protein 1 isoform X11
regulating synaptic membrane exocytosis protein 1 isoform X9
regulating synaptic membrane exocytosis protein 1 isoform X6
regulating synaptic membrane exocytosis protein 1 isoform X8
growth factor receptor-bound protein 2, transcript variant X2
growth factor receptor-bound protein 2, transcript variant X1
protein arginine N-methyltransferase 6, transcript variant X2
protein arginine N-methyltransferase 6, transcript variant X1
protein arginine N-methyltransferase 6, transcript variant X3
DNA-directed RNA polymerases I, II, and III subunit RPABC1
uncharacterized LOC124949267, transcript variant X5
protein arginine N-methyltransferase 6 isoform X1
protein arginine N-methyltransferase 6 isoform X3
protein arginine N-methyltransferase 6 isoform X2
uncharacterized LOC124949267, transcript variant X7
uncharacterized LOC124949267, transcript variant X2
uncharacterized LOC124949267, transcript variant X3
uncharacterized LOC124949267, transcript variant X6
uncharacterized LOC124949267, transcript variant X1
uncharacterized LOC124949267, transcript variant X8
uncharacterized LOC124949267, transcript variant X4
uncharacterized protein LOC124949267 isoform X2
uncharacterized protein LOC124949267 isoform X1
uncharacterized LOC124949270, transcript variant X6
uncharacterized LOC124949270, transcript variant X5
uncharacterized LOC124949270, transcript variant X3
uncharacterized LOC124949270, transcript variant X2
uncharacterized LOC124949270, transcript variant X1
uncharacterized LOC124949270, transcript variant X4
uncharacterized LOC124949275, transcript variant X2
uncharacterized LOC124949275, transcript variant X1
intraflagellar transport protein 46 homolog, transcript variant X2
intraflagellar transport protein 46 homolog, transcript variant X1
intraflagellar transport protein 46 homolog isoform X2
intraflagellar transport protein 46 homolog isoform X1
sodium-dependent nutrient amino acid transporter 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
sodium-dependent nutrient amino acid transporter 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
sodium-dependent nutrient amino acid transporter 1-like isoform X1
sodium-dependent nutrient amino acid transporter 1-like isoform X3
sodium-dependent nutrient amino acid transporter 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sodium-dependent nutrient amino acid transporter 1-like isoform X2
uncharacterized LOC124949254, transcript variant X3
uncharacterized LOC124949254, transcript variant X1
uncharacterized LOC124949254, transcript variant X2
uncharacterized protein LOC124949254 isoform X3
uncharacterized protein LOC124949254 isoform X2
uncharacterized protein LOC124949254 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
sodium-dependent nutrient amino acid transporter 1-like
sodium-dependent nutrient amino acid transporter 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sodium-dependent nutrient amino acid transporter 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sodium-dependent nutrient amino acid transporter 1-like isoform X4
sodium-dependent nutrient amino acid transporter 1-like isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments
abscission/NoCut checkpoint regulator, transcript variant X1
abscission/NoCut checkpoint regulator, transcript variant X2
abscission/NoCut checkpoint regulator, transcript variant X3
abscission/NoCut checkpoint regulator, transcript variant X4
abscission/NoCut checkpoint regulator, transcript variant X5
abscission/NoCut checkpoint regulator, transcript variant X6
abscission/NoCut checkpoint regulator isoform X1
abscission/NoCut checkpoint regulator isoform X2
BAG domain-containing protein Samui, transcript variant X1
BAG domain-containing protein Samui, transcript variant X3
BAG domain-containing protein Samui, transcript variant X2
BAG domain-containing protein Samui isoform X1
BAG domain-containing protein Samui isoform X2
BAG domain-containing protein Samui, transcript variant X6
BAG domain-containing protein Samui, transcript variant X10
BAG domain-containing protein Samui, transcript variant X8
BAG domain-containing protein Samui, transcript variant X4
BAG domain-containing protein Samui, transcript variant X5
BAG domain-containing protein Samui, transcript variant X9
BAG domain-containing protein Samui, transcript variant X7
F-box/LRR-repeat protein 7-like, transcript variant X1
F-box/LRR-repeat protein 7-like isoform X1
F-box/LRR-repeat protein 7-like, transcript variant X2
F-box/LRR-repeat protein 7-like isoform X2
dual specificity mitogen-activated protein kinase kinase dSOR1, transcript variant X3
dual specificity mitogen-activated protein kinase kinase dSOR1, transcript variant X1
dual specificity mitogen-activated protein kinase kinase dSOR1, transcript variant X2
dual specificity mitogen-activated protein kinase kinase dSOR1 isoform X1
dual specificity mitogen-activated protein kinase kinase dSOR1 isoform X2
synaptic vesicle glycoprotein 2B, transcript variant X2
synaptic vesicle glycoprotein 2B, transcript variant X1
transfer RNA arginine (anticodon UCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC124949375, transcript variant X3
uncharacterized LOC124949375, transcript variant X1
uncharacterized LOC124949375, transcript variant X2
E3 ubiquitin-protein ligase arih1, transcript variant X4
E3 ubiquitin-protein ligase arih1, transcript variant X1
E3 ubiquitin-protein ligase arih1, transcript variant X5
E3 ubiquitin-protein ligase arih1, transcript variant X3
E3 ubiquitin-protein ligase arih1, transcript variant X2
E3 ubiquitin-protein ligase arih1, transcript variant X7
E3 ubiquitin-protein ligase arih1, transcript variant X6
serine/threonine-protein kinase ULK3, transcript variant X3
serine/threonine-protein kinase ULK3, transcript variant X1
serine/threonine-protein kinase ULK3, transcript variant X4
serine/threonine-protein kinase ULK3, transcript variant X5
serine/threonine-protein kinase ULK3, transcript variant X6
serine/threonine-protein kinase ULK3, transcript variant X2
serine/threonine-protein kinase ULK3 isoform X1
serine/threonine-protein kinase ULK3 isoform X3
serine/threonine-protein kinase ULK3 isoform X2
serine/threonine-protein kinase ULK3 isoform X5
serine/threonine-protein kinase ULK3 isoform X4
uncharacterized LOC124949369, transcript variant X1
uncharacterized LOC124949369, transcript variant X4
uncharacterized protein LOC124949369 isoform X4
uncharacterized LOC124949369, transcript variant X6
uncharacterized LOC124949369, transcript variant X3
uncharacterized LOC124949369, transcript variant X5
uncharacterized LOC124949369, transcript variant X2
uncharacterized protein LOC124949369 isoform X5
uncharacterized protein LOC124949369 isoform X2
uncharacterized protein LOC124949369 isoform X1
uncharacterized protein LOC124949369 isoform X3
uncharacterized protein LOC124949369 isoform X6
uncharacterized protein LOC124949477 isoform X3
uncharacterized LOC124949478, transcript variant X1
uncharacterized LOC124949478, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16% coverage of the annotated genomic feature by RNAseq alignments
zwei Ig domain protein zig-8-like, transcript variant X2
zwei Ig domain protein zig-8-like, transcript variant X3
zwei Ig domain protein zig-8-like, transcript variant X4
zwei Ig domain protein zig-8-like, transcript variant X1
zwei Ig domain protein zig-8-like, transcript variant X7
zwei Ig domain protein zig-8-like, transcript variant X13
zwei Ig domain protein zig-8-like, transcript variant X5
zwei Ig domain protein zig-8-like, transcript variant X6
zwei Ig domain protein zig-8-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zwei Ig domain protein zig-8-like, transcript variant X9
zwei Ig domain protein zig-8-like, transcript variant X10
zwei Ig domain protein zig-8-like, transcript variant X12
zwei Ig domain protein zig-8-like, transcript variant X11
zwei Ig domain protein zig-8-like isoform X1
zwei Ig domain protein zig-8-like isoform X2
zwei Ig domain protein zig-8-like isoform X3
gonadotropin-releasing hormone receptor, transcript variant X3
gonadotropin-releasing hormone receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
gonadotropin-releasing hormone receptor, transcript variant X2
gonadotropin-releasing hormone receptor isoform X1
gonadotropin-releasing hormone receptor isoform X3
gonadotropin-releasing hormone receptor isoform X2
Wilms tumor protein homolog, transcript variant X2
Wilms tumor protein homolog, transcript variant X5
Wilms tumor protein homolog, transcript variant X3
Wilms tumor protein homolog, transcript variant X1
Wilms tumor protein homolog, transcript variant X4
cilia- and flagella-associated protein 43-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 3% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein basonuclin-2-like, transcript variant X1
zinc finger protein basonuclin-2-like, transcript variant X2
zinc finger protein basonuclin-2-like, transcript variant X6
zinc finger protein basonuclin-2-like, transcript variant X7
zinc finger protein basonuclin-2-like, transcript variant X4
zinc finger protein basonuclin-2-like, transcript variant X5
zinc finger protein basonuclin-2-like, transcript variant X8
zinc finger protein basonuclin-2-like, transcript variant X3
zinc finger protein basonuclin-2-like isoform X1
zinc finger protein basonuclin-2-like isoform X2
zinc finger protein basonuclin-2-like isoform X4
zinc finger protein basonuclin-2-like isoform X3
zinc finger protein basonuclin-2-like isoform X5
zinc finger protein basonuclin-2-like, transcript variant X9
uncharacterized protein LOC124949564 isoform X6
uncharacterized LOC124949565, transcript variant X2
uncharacterized LOC124949565, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124949283, transcript variant X2
uncharacterized LOC124949283, transcript variant X1
uncharacterized protein LOC124949283 isoform X2
uncharacterized protein LOC124949283 isoform X1
G-patch domain and KOW motifs-containing protein
katanin p60 ATPase-containing subunit A-like 2, transcript variant X2
katanin p60 ATPase-containing subunit A-like 2, transcript variant X7
katanin p60 ATPase-containing subunit A-like 2, transcript variant X1
katanin p60 ATPase-containing subunit A-like 2, transcript variant X6
katanin p60 ATPase-containing subunit A-like 2, transcript variant X3
katanin p60 ATPase-containing subunit A-like 2, transcript variant X5
katanin p60 ATPase-containing subunit A-like 2, transcript variant X11
katanin p60 ATPase-containing subunit A-like 2 isoform X1
katanin p60 ATPase-containing subunit A-like 2, transcript variant X8
katanin p60 ATPase-containing subunit A-like 2, transcript variant X9
katanin p60 ATPase-containing subunit A-like 2, transcript variant X4
katanin p60 ATPase-containing subunit A-like 2, transcript variant X10
katanin p60 ATPase-containing subunit A-like 2, transcript variant X12
katanin p60 ATPase-containing subunit A-like 2 isoform X2
katanin p60 ATPase-containing subunit A-like 2 isoform X3
survival motor neuron protein, transcript variant X2
survival motor neuron protein, transcript variant X1
survival motor neuron protein isoform X2
survival motor neuron protein isoform X1
WD repeat-containing protein 37, transcript variant X2
WD repeat-containing protein 37, transcript variant X1
WD repeat-containing protein 37 isoform X1
WD repeat-containing protein 37, transcript variant X3
WD repeat-containing protein 37 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
adenylosuccinate synthetase, transcript variant X1
adenylosuccinate synthetase, transcript variant X2
homeobox protein engrailed-2-B, transcript variant X1
homeobox protein engrailed-2-B, transcript variant X2
basal body-orientation factor 1, transcript variant X1
basal body-orientation factor 1, transcript variant X2
basal body-orientation factor 1 isoform X1
basal body-orientation factor 1 isoform X2
DNA polymerase epsilon catalytic subunit 1, transcript variant X3
DNA polymerase epsilon catalytic subunit 1, transcript variant X1
DNA polymerase epsilon catalytic subunit 1 isoform X1
DNA polymerase epsilon catalytic subunit 1 isoform X3
DNA polymerase epsilon catalytic subunit 1, transcript variant X2
DNA polymerase epsilon catalytic subunit 1 isoform X2
ATP synthase-coupling factor 6, mitochondrial, transcript variant X1
ATP synthase-coupling factor 6, mitochondrial, transcript variant X2
ATP synthase-coupling factor 6, mitochondrial, transcript variant X3
ATP synthase-coupling factor 6, mitochondrial isoform X1
ATP synthase-coupling factor 6, mitochondrial isoform X2
paired box pox-meso protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
paired box pox-meso protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
paired box pox-meso protein-like, transcript variant X2
paired box pox-meso protein-like, transcript variant X4
paired box pox-meso protein-like isoform X2
paired box pox-meso protein-like isoform X1
paired box pox-meso protein-like, transcript variant X7
paired box pox-meso protein-like, transcript variant X5
paired box pox-meso protein-like, transcript variant X6
snRNA-activating protein complex subunit 3, transcript variant X1
snRNA-activating protein complex subunit 3 isoform X1
snRNA-activating protein complex subunit 3, transcript variant X2
snRNA-activating protein complex subunit 3 isoform X2
protein O-mannosyl-transferase TMTC4-like, transcript variant X1
protein O-mannosyl-transferase TMTC4-like, transcript variant X2
protein O-mannosyl-transferase TMTC4-like, transcript variant X3
protein O-mannosyl-transferase TMTC4-like isoform X2
protein O-mannosyl-transferase TMTC4-like isoform X1
protein O-mannosyl-transferase TMTC4-like isoform X3
uncharacterized LOC124949096, transcript variant X2
uncharacterized LOC124949096, transcript variant X3
uncharacterized LOC124949096, transcript variant X4
uncharacterized LOC124949096, transcript variant X1
uncharacterized protein LOC124949096 isoform X2
uncharacterized protein LOC124949096 isoform X1
WD repeat domain-containing protein 83, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
WD repeat domain-containing protein 83, transcript variant X1
very low-density lipoprotein receptor-like, transcript variant X2
very low-density lipoprotein receptor-like, transcript variant X5
very low-density lipoprotein receptor-like, transcript variant X1
very low-density lipoprotein receptor-like, transcript variant X3
very low-density lipoprotein receptor-like, transcript variant X4
very low-density lipoprotein receptor-like, transcript variant X10
very low-density lipoprotein receptor-like, transcript variant X7
very low-density lipoprotein receptor-like, transcript variant X8
very low-density lipoprotein receptor-like, transcript variant X9
very low-density lipoprotein receptor-like, transcript variant X11
very low-density lipoprotein receptor-like isoform X1
very low-density lipoprotein receptor-like isoform X3
very low-density lipoprotein receptor-like isoform X2
very low-density lipoprotein receptor-like isoform X7
very low-density lipoprotein receptor-like isoform X5
very low-density lipoprotein receptor-like isoform X8
very low-density lipoprotein receptor-like isoform X6
low-density lipoprotein receptor-like isoform X9
very low-density lipoprotein receptor-like, transcript variant X6
very low-density lipoprotein receptor-like isoform X4
GATOR complex protein NPRL3, transcript variant X1
GATOR complex protein NPRL3, transcript variant X3
GATOR complex protein NPRL3, transcript variant X2
uncharacterized LOC124949109, transcript variant X1
uncharacterized LOC124949109, transcript variant X2
uncharacterized LOC124949109, transcript variant X4
uncharacterized LOC124949109, transcript variant X3
uncharacterized protein LOC124949109 isoform X2
uncharacterized protein LOC124949109 isoform X1
uncharacterized protein LOC124949109 isoform X3
pleckstrin homology domain-containing family J member 1-like
pleiotropic regulator 1, transcript variant X1
pleiotropic regulator 1, transcript variant X2
40S ribosomal protein SA, transcript variant X3
40S ribosomal protein SA, transcript variant X2
40S ribosomal protein SA, transcript variant X1
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1
deoxyribonuclease TATDN1, transcript variant X1
deoxyribonuclease TATDN1, transcript variant X2
neuronal acetylcholine receptor subunit alpha-2-like, transcript variant X4
neuronal acetylcholine receptor subunit alpha-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
neuronal acetylcholine receptor subunit alpha-2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
neuronal acetylcholine receptor subunit alpha-2-like isoform X1
neuronal acetylcholine receptor subunit alpha-2-like isoform X2
neuronal acetylcholine receptor subunit alpha-2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
neuronal acetylcholine receptor subunit alpha-2-like isoform X3
neuronal acetylcholine receptor subunit alpha-2-like isoform X4
neuronal acetylcholine receptor subunit alpha-6-like, transcript variant X2
neuronal acetylcholine receptor subunit alpha-6-like, transcript variant X1
neuronal acetylcholine receptor subunit alpha-6-like isoform X1
neuronal acetylcholine receptor subunit alpha-6-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 9% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 87% coverage of the annotated genomic feature by RNAseq alignments
putative uncharacterized protein DDB_G0271606
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20% coverage of the annotated genomic feature by RNAseq alignments
ELKS/Rab6-interacting/CAST family member 1, transcript variant X1
ELKS/Rab6-interacting/CAST family member 1, transcript variant X2
ELKS/Rab6-interacting/CAST family member 1 isoform X1
ELKS/Rab6-interacting/CAST family member 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
ELKS/Rab6-interacting/CAST family member 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: adenylate cyclase type 10-like
nucleoplasmin-like protein, transcript variant X2
nucleoplasmin-like protein, transcript variant X1
uncharacterized LOC124949257, transcript variant X1
uncharacterized LOC124949257, transcript variant X2
muscle segmentation homeobox-like, transcript variant X2
muscle segmentation homeobox-like, transcript variant X1
muscle segmentation homeobox-like isoform X1
muscle segmentation homeobox-like isoform X2
homeobox protein Nkx-2.3-like, transcript variant X2
homeobox protein Nkx-2.3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
myb-like protein Q, transcript variant X3
myb-like protein Q, transcript variant X2
myb-like protein Q, transcript variant X1
uncharacterized LOC124949115, transcript variant X1
uncharacterized LOC124949115, transcript variant X2
uncharacterized LOC124949179, transcript variant X1
uncharacterized LOC124949179, transcript variant X4
uncharacterized LOC124949179, transcript variant X2
uncharacterized LOC124949179, transcript variant X3
uncharacterized LOC124949179, transcript variant X5
uncharacterized LOC124949179, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC124949179, transcript variant X6
uncharacterized LOC124949179, transcript variant X8
uncharacterized protein LOC124949179 isoform X2
uncharacterized protein LOC124949179 isoform X1
uncharacterized protein LOC124949179 isoform X3
uncharacterized protein LOC124949179 isoform X4
uncharacterized protein LOC124949179 isoform X5
uncharacterized protein C9orf85 homolog, transcript variant X2
uncharacterized protein C9orf85 homolog isoform X2
uncharacterized protein C9orf85 homolog, transcript variant X1
28S ribosomal protein S29, mitochondrial, transcript variant X2
28S ribosomal protein S29, mitochondrial, transcript variant X1
28S ribosomal protein S29, mitochondrial isoform X1
28S ribosomal protein S29, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 73% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC124949438
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 79% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124949280, transcript variant X2
uncharacterized LOC124949280, transcript variant X3
uncharacterized LOC124949280, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 239 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124949313, transcript variant X1
uncharacterized LOC124949313, transcript variant X2
uncharacterized LOC124949313, transcript variant X3
protein spaetzle 3, transcript variant X4
protein spaetzle 3, transcript variant X1
protein spaetzle 3, transcript variant X2
protein spaetzle 3, transcript variant X3
putative cyclin-dependent serine/threonine-protein kinase DDB_G0272797/DDB_G0274007
chromosome-associated kinesin KIF4, transcript variant X1
chromosome-associated kinesin KIF4, transcript variant X2
chromosome-associated kinesin KIF4, transcript variant X3
chromosome-associated kinesin KIF4, transcript variant X4
chromosome-associated kinesin KIF4 isoform X1
chromosome-associated kinesin KIF4 isoform X2
CD151 antigen-like, transcript variant X2
CD151 antigen-like, transcript variant X1
CD151 antigen-like, transcript variant X4
CD151 antigen-like, transcript variant X3
CD151 antigen-like, transcript variant X5
transfer RNA alanine (anticodon CGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 94% coverage of the annotated genomic feature by RNAseq alignments
myb-like protein O, transcript variant X1
myb-like protein O, transcript variant X2
myb-like protein O, transcript variant X3
myb-like protein O, transcript variant X6
myb-like protein O, transcript variant X4
myb-like protein O, transcript variant X5
heterogeneous nuclear ribonucleoprotein K, transcript variant X2
heterogeneous nuclear ribonucleoprotein K, transcript variant X3
heterogeneous nuclear ribonucleoprotein K, transcript variant X4
heterogeneous nuclear ribonucleoprotein K, transcript variant X1
heterogeneous nuclear ribonucleoprotein K isoform X1
heterogeneous nuclear ribonucleoprotein K isoform X2
cytochrome b5-like, transcript variant X2
cytochrome b5-like, transcript variant X1
cytochrome b5-like, transcript variant X3
pupal cuticle protein 20-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
pupal cuticle protein 20-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
pupal cuticle protein 20-like, transcript variant X1
pupal cuticle protein 20-like, transcript variant X5
pupal cuticle protein 20-like, transcript variant X2
pupal cuticle protein 20-like isoform X1
pupal cuticle protein 20-like isoform X2
uncharacterized LOC124949200, transcript variant X2
uncharacterized LOC124949200, transcript variant X1
phospholipid-transporting ATPase ABCA1-like, transcript variant X3
phospholipid-transporting ATPase ABCA1-like, transcript variant X1
phospholipid-transporting ATPase ABCA1-like, transcript variant X2
phospholipid-transporting ATPase ABCA1-like, transcript variant X4
ATP-binding cassette sub-family A member 7-like isoform X2
phospholipid-transporting ATPase ABCA1-like isoform X4
retinal-specific phospholipid-transporting ATPase ABCA4-like isoform X3
ATP-binding cassette sub-family A member 2-like isoform X1
phospholipid-transporting ATPase ABCA1-like, transcript variant X5
phospholipid-transporting ATPase ABCA1-like isoform X5
transforming acidic coiled-coil-containing protein 3-like
uncharacterized LOC124949199, transcript variant X2
uncharacterized LOC124949199, transcript variant X1
protein limb expression 1 homolog, transcript variant X4
protein limb expression 1 homolog, transcript variant X2
protein limb expression 1 homolog, transcript variant X1
protein limb expression 1 homolog, transcript variant X6
protein limb expression 1 homolog, transcript variant X3
protein limb expression 1 homolog, transcript variant X5
ATP-dependent Clp protease proteolytic subunit
uncharacterized LOC124949061, transcript variant X2
uncharacterized LOC124949061, transcript variant X5
uncharacterized LOC124949061, transcript variant X3
uncharacterized LOC124949061, transcript variant X1
uncharacterized protein LOC124949061 isoform X2
uncharacterized protein LOC124949061 isoform X1
uncharacterized protein LOC124949061 isoform X5
uncharacterized protein LOC124949061 isoform X3
uncharacterized LOC124949061, transcript variant X4
uncharacterized protein LOC124949061 isoform X4
Sjoegren syndrome nuclear autoantigen 1 homolog, transcript variant X3
Sjoegren syndrome nuclear autoantigen 1 homolog, transcript variant X5
Sjoegren syndrome nuclear autoantigen 1 homolog, transcript variant X2
Sjoegren syndrome nuclear autoantigen 1 homolog, transcript variant X4
Sjoegren syndrome nuclear autoantigen 1 homolog, transcript variant X1
Sjoegren syndrome nuclear autoantigen 1 homolog isoform X1
Sjoegren syndrome nuclear autoantigen 1 homolog isoform X2
maternal protein tudor-like, transcript variant X5
maternal protein tudor-like, transcript variant X4
maternal protein tudor-like, transcript variant X3
maternal protein tudor-like, transcript variant X1
maternal protein tudor-like, transcript variant X2
E3 ubiquitin-protein ligase RNF146, transcript variant X1
E3 ubiquitin-protein ligase RNF146, transcript variant X2
E3 ubiquitin-protein ligase RNF146 isoform X1
E3 ubiquitin-protein ligase RNF146 isoform X2
uncharacterized LOC124949246, transcript variant X3
uncharacterized LOC124949246, transcript variant X2
uncharacterized LOC124949246, transcript variant X1